Table 6.
Prevalence of the general side effects after 1st dose Sinopharm COVID-19 Sinopharm COVID-19 vaccination among 2 group of participants (females vs males), n (1080)
| Side Effect | Female (760) | Percent | Male (320) | Percent | Total (1080) | Percent | p-value |
|---|---|---|---|---|---|---|---|
| Normal Pain at the vaccination site | 312 | 41% | 144 | 45.0% | 456 | 42.2% | 0.571 |
| Sever pain at the vaccination site | 28 | 3.7% | 0 | 0 | 28 | 2.6% | 0.081 |
| Tenderness | 48 | 6.3% | 8 | 2.5% | 56 | 5.2% | 0.194 |
| Redness | 8 | 1.0% | 0 | 0 | 8 | 0.7% | 0.356 |
| Induration and pruritus at the vaccination site | 12 | 1.6% | 0 | 0 | 12 | 1.0% | 0.257 |
| Fever | 8 | 1.1% | 4 | 1.25% | 12 | 1.0% | 0.891 |
| Headache | 80 | 10.5% | 24 | 7.5% | 104 | 9.6% | 0.434 |
| Fatigue | 120 | 15.8% | 12 | 3.75% | 132 | 12.2% | 0.006 |
| Nausea | 16 | 2.1% | 0 | 0 | 16 | 1.5% | 0.190 |
| Diarrhea | 8 | 1.1% | 0 | 0 | 8 | 0.7% | 0.356 |
| Cough | 12 | 1.6% | 0 | 0 | 12 | 1.0% | 0.257 |
| Allergy | 8 | 1.0% | 4 | 1.25% | 12 | 1.0% | 0.891 |
| Muscle pain | 60 | 7.9% | 8 | 2.5% | 68 | 6.3% | 0.094 |
| Abdominal Pain | 20 | 2.6% | 0 | 0 | 20 | 1.8% | 0.142 |
| Back pain | 44 | 5.8% | 0 | 0 | 44 | 4.1% | 0.028 |
| Lethargy | 96 | 12.6% | 4 | 1.25% | 100 | 9.3% | 0.003 |
| I did not get any side effect | 132 | 17.0% | 144 | 45.0% | 264 | 24.0% | 0.000 |
Bolded numbers are significant